Pharmacists News
- Georgia Ban on Transgender Healthcare Challenged in Lawsuit
- Madrigal Opens Submission for NASH Drug Application With FDA
- Drugmaker Partners Launch Copycat for Arthritis Drug Humira
- Bausch + Lomb Buys Novartis Drugs for $1.75 Billion
- Medical Cannabis Does Not Reduce Use of Prescription Meds
- Race, Ethnicity Loom Large in CRC Screening
- ADA 2023 COORDINATE-Diabetes: a 'Wake-Up Call' for Many Specialties
- Do Oral Contraceptives Increase Depression Risk?
- IBD Study Characterizes Biologic Adherence
- ADA 2023 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
- AHS 2023 Children of Color Get Less Testing, Diagnosis of Migraine
- Study Evaluates Pregnancy Risks With Biologics for Psoriasis
- Diabetes May Short Circuit Pembrolizumab Benefits in NSCLC
- GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis
- HRT, Even Short-Term Use, Linked to Dementia Risk in Women
- End-of-Life Cancer Care Varies by Race, Insurance, Setting
- Review Finds Biosimilars for Psoriasis Safe, Effective
- ADA 2023 Survodutide Impresses in Phase 2 Weight-Loss Trial
- New ESH Hypertension Guidelines Aim for Simplified Message
- How Physician Chefs Perfect Life-Saving Cuisine